Q4 earnings for companies such as Johnson & Johnson, Teva, and Roche highlight the impact of significant innovations brought ...

as well as cancer drug Erleada (apalutamide) and Stelara follow-up Tremfya (guselkumab). Chief executive Joaquin Duato said that J&J has a "strong foundation for near and long-term growth", thanks ...

This study aimed to investigate the nature of life impacts following ankle fractures with the intention of describing a thematic conceptual framework based on these lived experiences of people who ...

During an in-person Community Case Forum event in Miami, Florida, Mike Cusnir, MD, discussed the ARANOTE study outcomes presented at ESMO 2024 and how they fit into the treatment paradigm for patients ...